X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

ICSE China 2016 – A gala event for pharma CRO & CMO industry

Yuvraj_pawp by Yuvraj_pawp
20th February 2016
in Research & Development

ICSE China 2016, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo,will be held on 21 – 23rd June at Hall E2 in Shanghai New International Expo Centre, together with CPhI China.

As the global pharmaceutical product regulations become increasingly strict and pharmaceutical product’s R&D continues to become more demanding in recent years, in order to keep the profitability of pharmaceutical products in their entire life cycle, many transnational pharmaceutical enterprises have gradually turned their business model from “vertical integration” to “cooperation in development”. Decomposition of business links such as research, development and production of patented drugs, and outsourced them to pharmaceutical contract research organizations (CRO) and pharmaceutical contract manufacture organizations (CMO), etc. pharmaceutical contract service industry has formally entered the fast lane of development.

Reduction of drug R&D costs, growth of market share and increasing proportion of outsourcing have become an important means for transnational companies in developed countries to respond to market changes. China, as one of the most significant pharmerging markets, has been attracting more and more attention from Europe and America thanks to the virtue of inherent cost- effective advantage and gradually enhanced R&D production capabilities. ICSE China, as the exclusive CRO & CMO themed exhibition in China approved by the Ministry of Commerce of the P.R.C., is committed to create an international display platform for pharmaceutical contract service enterprises, and building a bridge for Chinese and overseas pharmaceutical enterprises and R&D institutions.

With the special advantage of CPhI global shows and constant increase of profile in China and overseas, ICSE China has become one of the important ways for Chinese contract pharmaceutical service enterprises to expand their overseas markets, and become much popular with new and regular exhibitors. CROs & CMOs including Porton ABA, UNICHEMIST, Chemspec, HaimenRuiyi, Granules-Biocause, Molbase, BSAZ, YWK Chemicals, Topharman, AccelaChemBio, Innovating, BONTAC and T&W, etc. have confirmed their continued participation, and will centrally showcase their latest technologies in fields such as custom synthesis, biotechnological clinical research, medicinal chemistry, registration and legislation associated services, process development/optimization, process scale-up production, API synthesis production, intermediate synthesis production and preparation production.

ICSE China will be co-located with BioPh China in the same hall of SNIEC, the two themed areas will focus on biological products and technologies, innovative products and quality brands among CROs & CMOs, and the discussion concerning industry dynamics and seeking of industry opportunities with industry professionals. The interaction of the two will also provide a convenient visiting channel for professionals in industries associated with pharmaceutical R&D, and provide buyers and enterprises with a R&D and/or procurement platform of unprecedented size and R&D solutions by gathering the numerous contract service and biopharmaceutical suppliers. In addition, Pharmaceutical R&D Innovation and Outsourcing Management Conference will be held during the show, offering visitors opportunitiesto find the best partners and obtain new ideas of constructing innovative partnership from the sharing of persons in charge of transnational pharmaceutical enterprises and Chinese innovative pharmaceutical enterprises.

Online visitor registration is now open! Please visit http://www.cphi.com/china to register or contact Ms. Tina Zheng (tina.zheng@ubmsinoexpo.com) for more information.

Previous Post

How pharma can stay competitive in the digital world

Next Post

Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

Related Posts

Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows
Manufacturing

Commercial Success In New Biopharmaceutical Innovation Era

21st May 2022
Manufacturing

Proteros and AstraZeneca Boost Collaboration Agreement

18th May 2022
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Middle East and South Asia

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

22nd March 2022
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
Press Statements

Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines

17th January 2022
COVID-19 Impact On Changing Pharma Research And Development
News

COVID-19 Impact On Changing Pharma Research And Development

12th January 2022
immuno-oncology therapies
Drug Development

AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025

19th November 2021
Next Post

Grasp the opportunity at Emerging Markets for High Growth of Life Science and Chemical Instrumentation

Latest News

Dupixent From Sanofi Delivers Another Fantastic Performance
Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

5th July 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

Singapore Authorises New Ovarian Cancer Treatment By GSK

5th July 2022
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
Manufacturing

Abbott India Affirms That The Medicines Are Not Their Own

5th July 2022
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Manufacturing

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

4th July 2022
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
Manufacturing

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

4th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In